CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

Name: CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

Starting Price : $5000.00 $3500.00 | Pages : 247 | Published : September 2021 | | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

CAR-T Therapy Market Definition

The chimeric antigen receptor -T therapy market consists of sales of CAR-T therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (CAR) T-cell therapies to treat blood cancers.

CAR-T therapy is type of immunotherapy in which T-cells taken from patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as the chimeric antigen receptor (CAR), attaches to a specific protein on a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.

This industry includes establishments that are involved in the research and development to introduce new targeted cell therapies for treating indications related mostly to hematological malignancies. However, some of the pipeline CAR-T therapies are aimed at targeting solid tumors including pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain tumor, and other cancer types.

Book your 30 minutes free consultation with our research experts

CAR-T Therapy Market Size

The global CAR-T therapy market reached a value of nearly $1,037 million in 2020. The market is expected to grow from $1,037.0 million in 2020 to $3,150.0 million in 2025 at a rate of 24.9%. The growth is mainly due to an increased prevalence of cancer and increased awareness about the therapy. The market is expected to stabilize $ 6,100 million in 2030.

Growth in the historic period resulted from increases in healthcare expenditure, increase in pharmaceutical R&D expenditure and advances in drug discovery. This growth was restricted by low rate of drug approvals, challenges due to regulatory changes and limited number of treatment centers.

Going forward, increase in blood cancer incidence rate, rise in healthcare expenditure, strong pipeline of drugs and rising focus on car-t therapy are expected to drive the market. High costs of therapy, reimbursement challenges, adverse events, complex manufacturing and supply chain and covid-19 impacting drug trails, and reduction in free trade are major factors that could hinder the growth of the CAR-T therapy market in the future.

CAR-T Therapy Market Drivers

The key drivers of the CAR-T therapy market include:

Increase in Blood Cancer Incidence Rate

The rise in the number of blood cancer cases across the globe is likely to contribute to the growth of the CAR-T therapy market during the forecast period. According to the American Cancer Society, there were 1,762,450 new cases and 606,880 cancer deaths in 2019 in the USA. New cases of leukemia, lymphoma and myeloma are expected to account for 9.9% of the estimated 1,806,590 new cancer cases diagnosed in the US in 2020 and in approximately every 3 minutes one person in the US is diagnosed with a blood cancer. Therefore, the rise in the blood cancer incidence rate globally is anticipated to boost the demand for the CAR-T therapy market over the forthcoming years.

CAR-T Therapy Market Restraints

The key restraints on the CAR-T therapy market include:

High Costs Of Therapy

High costs associated with the CAR-T therapy is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. According to a 2019 study, factoring in all the costs associated with CAR T-cell therapy, hospitals may charge as much as $1.5 million to avoid losing money, thus restraining the growth of the market.

CAR-T Therapy Market Trends

Major trends influencing the CAR-T therapy market include:

Remodeled CAR-T Cell Therapy For Fewer Side Effects

The developers and providers of the CAR-T therapy market are investing in research and development to remodel the design of CAR-T therapy to reduce its side effects on cancer patients. The original CAR-T therapy causes neurologic side effects such as delirium, speech problems, seizures and tremors though it provides long-lasting remissions for some patients with very advanced cancer. The remodeled CAR-T therapy with a renewed design results in far fewer neurologic side effects than that of the original therapy. It also helps to reduce the levels of cytokines which cause neurologic side effects. For instance, in February 2020, the National Cancer Institute in the United States modified the design of the original CAR-T therapy and conducted it on 20 patients as trial. The results showed that only one patient out of the 20 in the trial had severe neurologic side effects. The new CAR-T therapy also resulted in the slow growth of tumors and minimized the levels of cytokines.

Collaborating With Technology Companies for Advanced Technologies:

Companies in the CAR-T therapy market are increasingly partnering or collaborating with technologies companies to integrate advanced technologies for the betterment of CAR-T therapy. Advanced technologies such as artificial intelligence (AI) and big data are used for personalizing and manufacturing improved CAR-T therapies. For instance, in October 2019, Novartis, a multinational pharmaceutical company headquartered in Switzerland, entered into a five-year partnership with Microsoft, a technology company headquartered in the United States, to develop and deploy the applications of its artificial intelligence capabilities on improving and personalizing the manufacturing of their CAR-T cancer therapies. The partnership also provides Microsoft the ability to test its AI technology for precise uses including CAR-T therapy manufacturing.

Opportunities And Recommendations In The CAR-T Therapy Market

Opportunities –The top opportunities in the CAR-T therapy market segmented by target antigen will arise in the CD19 segment, which will gain $790.0 million of global annual sales by 2025. The top opportunities in the CAR-T therapy market segmented by application will arise in the diffuse large B-cell lymphoma segment, which will gain $850.0 million of global annual sales by 2023. The CAR-T therapy market size will gain the most in the USA at $803.4 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the CAR-T therapy companies to focus on adoption of machine learning and artificial intelligence technologies, remodeled CAR-T cell therapy, expanding in countries offering advanced technologies, focus on developed markets, offer bundled payments, increase visibility through websites, focus on patient referral systems, focus on hospitals and other treatment centers among other strategies.

CAR-T Therapy Market Segmentation

The CAR-T therapy market is segmented by target antigen, by application, by geography.
By Target Antigen –
The CAR-T therapy market is segmented by target antigen into

a) CD19
b) CD22
c) BCMA
d) Others

The CD19 was the largest segment of the CAR-T therapy market by target antigen, accounting for 100% of the total market in 2020. Going forward, CD19 segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 12.0%.
By Application –
The CAR-T therapy market is segmented by application into

a) Acute Lymphoblastic Leukemia
b) Diffuse Large B-Cell Lymphoma
c) Follicular Lymphoma
d) Chronic Lymphocytic Leukemia
e) Multiple Myeloma
f) Others

The diffuse large B-cell lymphoma was the largest segment of the CAR-T therapy market by application, accounting for 54.0% of the total market in 2020. Going forward, the others segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 71.1%.
By Geography-
The CAR-T therapy market is segmented by geography into

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA

• Brazil

• France
• Germany
• UK

• Russia

North America was the largest region in the global CAR-T therapy market, accounting for 56.1% of the total in 2020. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the CAR-T therapy market will be Asia Pacific and Western Europe, where growth will be at CAGRs of 53.8% and 23.3% respectively.

CAR-T Therapy Competitive Landscape

Major Competitors In The CAR-T Therapy Market Are:

Gilead Sciences

Novartis AG

Other Competitors In The CAR-T Therapy Market Include:

Biocon (India)

Gracell Biotechnology Ltd

Aeon Therapeutics

CARsgen Therapeutics

Daiichi Sankyo

Celegne

Otsuka Pharmaceutical

Ono Pharmaceutical

Japan Tissue Engineering

Nipro Corporation

Takeda Pharmaceutical Company

Astellas Pharma.

Innovative Cellular Therapeutics

Cellular Biomedicine Group

PersonGen Biomedicine

Hebei Senlang Biotech

Adaptimmune (UK)

Autolus Therapeutics

BioNTech

Cellectis

Celyad

Crescendo Biologics

GammaDelta Therapeutics

Biocad

Celgene Corporation

Johnson & Johnson

F. Hoffmann-La Roche Ltd

Eli Lilly and Company

Pfizer

Amgen

AstraZeneca

Bayer AG

Sandoz AG (A Novartis Division)

GlaxoSmithKline plc

Elekta (Saudi Arabia)

SudairPharma (Saudi Arabia)

AstraZeneca (Kuwait)

Janssen (Kuwait)

Novartis (Kuwait)

Roche (Kuwait)

Eurolab

Sanofi

Aspen

1. CAR-T Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1. Segmentation By Geography

6.2. Segmentation By Target Antigen

6.3. Segmentation By Application

7. CAR-T Therapy Market Characteristics

7.1. Market Definition

7.2. Market Segmentation By Target Antigen

7.2.1. CD19 Therapy

7.2.2. CD22 Therapy

7.2.3. BCMA Therapy

7.2.4. Others

7.3. Market Segmentation By Application

7.3.1. Acute Lymphoblastic Leukemia

7.3.2. Diffuse Large B-Cell Lymphoma

7.3.3. Follicular Lymphoma

7.3.4. Chronic Lymphocytic Leukemia

7.3.5. Multiple Myeloma

7.3.6. Others

8. CAR-T Therapy Market, COVID Impact Analysis

8.1. Impact On Global CAR-T Therapy

8.2. Impact On Global CAR-T Therapy Clinical Trials

8.3. Impact On People Undergoing CAR-T Therapy

8.4. Impact On Leading Global Oncology Companies

8.5. Future Outlook

9. CAR-T Therapy Market Trends And Strategies

9.1. Remodeled CAR-T Cell Therapy For Fewer Side Effects

9.2. Off-The-Shelf Allogeneic CAR-T Therapy For Improved Treatment

9.3. Next-Generation CAR-T Cells For Treatment Of High-Grade Glioma

9.4. Machine Learning And Artificial Intelligence To Optimize Future CAR-T Therapy

9.5. Collaborating With Technology Companies For Advanced Technologies

9.6. Growing Partnerships For Promoting CAR-T Therapy Market

10. Global CAR-T Therapy Market Size And Growth

10.1. Market Size

10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

10.2.1. Drivers Of The Market 2015 – 2020

10.2.2. Restraints On The Market 2015 – 2020

10.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

10.3.1. Drivers Of The Market 2020 – 2025

10.3.2. Restraints On The Market 2020 – 2025

11. Global CAR-T Therapy Market Segmentation

11.1. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

11.1.1. CD19

11.1.2. CD22

11.1.3. BCMA

11.2. Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

11.2.1. Diffuse Large B-Cell Lymphoma

11.2.2. Acute Lymphoblastic Leukemia

11.2.3. Follicular Lymphoma

11.2.4. Multiple Myeloma

12. CAR-T Therapy Market, Regional And Country Analysis

12.1. Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.2. Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific CAR-T Therapy Market

13.1. Asia-Pacific CAR-T Therapy Market Overview

13.1.1. Region Information

13.1.2. Market Information

13.1.3. Impact of COVID-19

13.1.4. Background Information

13.1.5. Government Initiatives

13.1.6. Regulations

13.1.7. Regulatory Bodies

13.1.8. Major Associations

13.1.9. Taxes Levied

13.1.10. Corporate Tax Structure

13.1.11. Investment

13.1.12. Major Companies

13.2. Asia-Pacific CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.3. Asia-Pacific CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.5. Asia-Pacific CAR-T Therapy Market: Country Analysis

13.6. China CAR-T Therapy Market

13.7. China CAR-T Therapy Market Overview

13.7.1. Country Information

13.7.2. Market Information

13.7.3. Impact of COVID-19

13.7.4. Background Information

13.7.5. Government Initiatives

13.7.6. Regulations

13.7.7. Regulatory Bodies

13.7.8. Major Associations

13.7.9. Taxes Levied

13.7.10. Corporate Tax Structure

13.7.11. Investment

13.7.12. Major Companies

13.8. China CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.9. China CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.10. China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.11. India CAR-T Therapy Market

13.12. India CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.13. India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.14. Japan CAR-T Therapy Market

13.15. Japan CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.16. Japan CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.17. Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.18. Australia CAR-T Therapy Market

13.19. Australia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.20. Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.21. Indonesia CAR-T Therapy Market

13.22. Indonesia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.23. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.24. South Korea CAR-T Therapy Market

13.25. South Korea CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

13.26. South Korea CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

13.27. South Korea CAR-T Therapy Market, Segmentation By Application , Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe CAR-T Therapy Market

14.1. Western Europe CAR-T Therapy Market Overview

14.1.1. Region Information

14.1.2. Market Information

14.1.3. Impact of COVID-19

14.1.4. Background Information

14.1.5. Government Initiatives

14.1.6. Regulations

14.1.7. Regulatory Bodies

14.1.8. Major Associations

14.1.9. Taxes Levied

14.1.10. Corporate Tax Structure

14.1.11. Investments

14.1.12. Major Companies

14.2. Western Europe CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.3. Western Europe CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

14.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.5. Western Europe CAR-T Therapy Market: Country Analysis

14.6. UK CAR-T Therapy Market

14.7. UK CAR-T Therapy Market Overview

14.7.1. Country Information

14.7.2. Market Information

14.7.3. Impact of COVID-19

14.7.4. Background Information

14.7.5. Government Initiatives

14.7.6. Regulations

14.7.7. Regulatory Bodies

14.7.8. Associations

14.7.9. Taxes Levied

14.7.10. Corporate Tax Structure

14.7.11. Investments

14.7.12. Major Companies

14.8. UK CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.9. UK CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

14.10. UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.11. Germany CAR-T Therapy Market

14.12. Germany CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.13. Germany CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

14.14. Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.15. France CAR-T Therapy Market

14.16. France CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.17. France CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

14.18. France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe CAR-T Therapy Market

15.1. Eastern Europe CAR-T Therapy Market Overview

15.1.1. Region Information

15.1.2. Market Information

15.1.3. Impact of COVID-19

15.1.4. Background Information

15.1.5. Government Initiatives

15.1.6. Regulations

15.1.7. Regulatory Bodies

15.1.8. Associations

15.1.9. Taxes Levied

15.1.10. Corporate Tax Structure

15.1.11. Investments

15.1.12. Major Companies

15.2. Eastern Europe CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

15.3. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.4. Eastern Europe CAR-T Therapy Market: Country Analysis

15.5. Russia CAR-T Therapy Market

15.6. Russia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

15.7. Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16. North America CAR-T Therapy Market

16.1. North America CAR-T Therapy Market Overview

16.1.1. Region Information

16.1.2. Market Information

16.1.3. Impact Of COVID-19

16.1.4. Background Information

16.1.5. Government Initiatives

16.1.6. Regulations

16.1.7. Regulatory Bodies

16.1.8. Major Associations

16.1.9. Taxes Levied

16.1.10. Corporate Tax Structure

16.1.11. Investments

16.1.12. Major Companies

16.2. North America CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.3. North America CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

16.4. North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.5. North America CAR-T Therapy Market: Country Analysis

16.6. USA CAR-T Therapy Market

16.7. USA CAR-T Therapy Market Overview

16.7.1. Country Information

16.7.2. Impact Of COVID-19

16.7.3. Market Information

16.7.4. Background Information

16.7.5. Government Initiatives

16.7.6. Regulations

16.7.7. Regulatory Bodies

16.7.8. Major Associations

16.7.9. Corporate Tax Structure

16.7.10. Investments

16.7.11. Major Companies

16.8. USA CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.9. USA CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

16.10. USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17. South America CAR-T Therapy Market

17.1. South America CAR-T Therapy Market Overview

17.1.1. Region Information

17.1.2. Market Information

17.1.3. COVID Impact

17.1.4. Background Information

17.1.5. Government Initiatives

17.1.6. Regulations

17.1.7. Regulatory Bodies

17.1.8. Major Associations

17.1.9. Taxes Levied

17.1.10. Corporate Tax Structure

17.1.11. Investments

17.1.12. Major Companies

17.2. South America CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

17.3. South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.4. South America CAR-T Therapy Market: Country Analysis

17.5. Brazil CAR-T Therapy Market

17.6. Brazil CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

17.7. Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

18. Middle East CAR-T Therapy Market

18.1.Middle East CAR-T Therapy Market Overview

18.1.1. Region Information

18.1.2. Market Information

18.1.3. Impact of COVID-19

18.1.4. Background Information

18.1.5. Government Initiatives

18.1.6. Regulations

18.1.7. Regulatory Bodies

18.1.8. Major Associations

18.1.9. Investments

18.1.10. Taxes Levied

18.1.11. Corporate Tax Structure

18.1.12. Major Companies

18.2. Middle East CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

18.3.Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19. Africa CAR-T Therapy Market

19.1.Africa CAR-T Therapy Market Overview

19.1.1. Region Information

19.1.2. Market Information

19.1.3. Impact Of COVID-19

19.1.4. Background Information

19.1.5. Government Initiatives

19.1.6. Regulations

19.1.7. Regulatory Bodies

19.1.8. Major Associations

19.1.9. Investments

19.1.10. Taxes Levied

19.1.11. Corporate Tax Structure

19.1.12. Major Companies

19.2. Africa CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

19.3.Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

20. Global CAR-T Therapy Market Competitive Landscape

20.1. Company Profiles

20.2. Gilead Sciences

20.2.1. Company Overview

20.2.2. Products And Services

20.2.3. Business Strategy

20.2.4. Financial Overview

20.3. Novartis AG

20.3.1. Company Overview

20.3.2. Products And Services

20.3.3. Business Strategy

20.3.4. Financial Overview

21. CAR-T Therapy Pipeline Analysis

21.1.Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020

21.2. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type

21.3.CAR T-Cell Therapy, Number Of Active Trials By Cancer Type

21.4. Global CAR-T Cell Therapy By Trial Site

21.5. Number of Molecules In Cancer Clinical Trails, By Target

21.6. CAR-T Cell Therapy Pipeline Analysis

22. Key Mergers And Acquisitions In The CAR-T Therapy Market

22.1. ResTORbio Merged With Adicet Bio

22.2. Astellas Pharma Acquired Xyphos Biosciences

22.3. Bristol Myers Squibb Acquired Celgene Corporation

22.4. Celgene Acquired Juno Therapeutics

22.5. Gilead Sciences Acquired Cell Design Labs

22.6. Gilead Sciences Acquired Kite Pharma

23. CAR-T Therapy Market Opportunities & Strategies

23.1.Global CAR-T Therapy Market In 2025 – Countries Offering Most New Opportunities

23.2. Global CAR-T Therapy Market In 2025 – Segments Offering Most New Opportunities

23.3.Global CAR-T Therapy Market In 2025 – Growth Strategies

23.3.1. Market Trend Based Strategies

23.3.2. Competitor Strategies

24. CAR-T Therapy Market, Conclusions And Recommendations

24.1. Conclusions

24.2. Recommendations

24.2.1. Product

24.2.2. Place

24.2.3. Price

24.2.4. Promotion

24.2.5. People

25. Appendix

25.1. Market Data Sources

25.2. Research Methodology

25.3. Currencies

25.4. Research Inquiries

25.5. The Business Research Company

25.6. Copyright and Disclaimer

List Of Tables

Table 1: Global CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 2: Global CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 3: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 4: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 5: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 6: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 7: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 8: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 9: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 10: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 11: Asia-Pacific CAR-T Therapy Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $

Table 12: Asia-Pacific CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands

Table 13: Asia-Pacific Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 14: Asia Pacific Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 15: Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 16: Asia-Pacific CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 17: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 18: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 19: China Per Capita Healthcare Expenditure, 2015-2019, $

Table 20: China CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands

Table 21: China Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 22: China Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 23: China CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 24: China CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 25: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 26: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio

Table 27: India CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 28: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 29: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 30: Japan CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 31: Japan CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 32: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 33: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 34: Australia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 35: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 36: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 37: Indonesia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 38: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 39: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 40: South Korea CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 41: South Korea CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 42: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 43: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 44: Western Europe Per Capita Healthcare Expenditure, 2015-2019, $

Table 45: Western Europe CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands

Table 46: Western Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 47: Western Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 48: Corporate Tax Structure In Western Europe Countries, %

Table 49: Western Europe CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 50: Western Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 51: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 52: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 53: UK Per Capita Healthcare Expenditure, 2015-2019, $

Table 54: UK CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands

Table 55: UK Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 56: UK Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 57: UK CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 58: UK CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 59: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 60: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 61: Germany CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 62: Germany CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 63: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 64: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 65: France CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 66: France CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 67: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 68: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 69: Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $

Table 70: Eastern Europe CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands

Table 71: Eastern Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 72: Eastern Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 73: Eastern Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 74: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 75: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 76: Russia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 77: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 78: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 79: North America Per Capita Healthcare Expenditure, 2015-2019, $

Table 80: North America CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands

Table 81: North America Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 82: North America Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 83: North America CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 84: North America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 85: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 86: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 87: USA Per Capita Healthcare Expenditure, 2015-2019, $

Table 88: USA CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands

Table 89: USA Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 90: USA Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 91: USA CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Table 92: USA CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 93: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 94: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 95: South America Per Capita Healthcare Expenditure, 2015-2019, $

Table 96: South America CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands

Table 97: South America Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 98: South America Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 99: South America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 100: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 101: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 102: Brazil CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 103: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 104: Brazil CAR-T Therapy Market, Segmentation By Application , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 105: Middle East Per Capita Healthcare Expenditure, 2015-2019, $

Table 106: Middle East CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands

Table 107: Middle East Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 108: Middle East Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 109: Middle East CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 110: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 111: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 112: Africa Per Capita Healthcare Expenditure, 2015-2019, $

Table 113: Africa CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands

Table 114: Africa Blood Cancer Drugs Market Size, 2015-2019, $ Billion

Table 115: Africa Five-Year Prevalence Of Blood Related Cancers, 2015-2019

Table 116: Africa CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 117: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 118: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 119: Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Table 120: Gilead Sciences – Financial Performance, 2016– 2020, $ Billion

Table 121: Novartis AG – Financial Performance, 2016 – 2020, $ Billion

Table 122: Pipeline Analysis Of CAR-T Cell Therapy

Table 123: Global CAR-T Therapy Market Size Gain ($ Million), 2020 – 2025, By Country

Table 124: Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Target Antigen, 2020 – 2025

Table 125: Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025

Table 126: CAR-T Therapy Market - Data Sources

List Of Figures

Figure 1: Global CAR-T Therapy Market Segmentation By Target Antigen

Figure 2: Global CAR-T Therapy Market Segmentation By Application

Figure 3: Global CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 4: Global CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 5: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 6: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 7: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 8: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 9: Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 10: Asia-Pacific CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 11: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 12: China CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 13: China CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 14: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 15: India CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 16: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 17: Japan CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 18: Japan CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 19: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 20: Australia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 21: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 22: Indonesia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 23: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 24: South Korea CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 25: South Korea CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 26: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 27: Western Europe CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 28: Western Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 29: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 30: UK CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 31: UK CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 32: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 33: Germany CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 34: Germany CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 35: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 36: France CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 37: France CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 38: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 39: Eastern Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 40: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 41: Russia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 42: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 43: North America CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 44: North America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 45: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 46: USA CAR-T Therapy Market, Historic, 2015 – 2020, $ Million

Figure 47: USA CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 48: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 49: South America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 50: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 51: Brazil CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 52: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 53: Middle East CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 54: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 55: Africa CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 56: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 57: Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Figure 58: Gilead Sciences – Financial Performance, 2016 – 2020, $ Billion

Figure 59: Novartis AG – Financial Performance, 2016– 2020, $ Billion

Figure 60: CAR-T Therapy Market, Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020

Figure 61: CAR-T Therapy Market, Number Of Active Trials By Cancer Type

Figure 62: CAR-T Therapy Market, Number Of Active Trials By Cancer Type

Figure 63: CAR-T Therapy Market, Global CAR-T Cell Therapy By Trial Site

Figure 64: CAR-T Therapy Market, Number of Molecules In Cancer Clinical Trials, By Target

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the fertility drugs market research report 2022 with industry size, share, segments and market growth

Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Sterility Testing Global Market Report 2024 – By Sample (Sterile Drugs, Medical Devices, Biologics and Therapeutics), By Product Type (Instruments, Kits and Reagents, Services), By Type (In- house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End- User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharma Microbiology Testing Kits Global Market Report 2024 – By Product (Consumables, Equipment), By Test (Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests), By End User (Hospitals & Diagnostic Centers, Custom Lab Service Providers, Academic & Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer Monoclonal Antibodies Global Market Report 2024 – By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others), By End-User (Hospitals, Research Laboratories, Others) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical API Manufacturing Global Market Report 2024 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Excipients Global Market Report 2024 – By Product (Inorganic Chemicals, Organic Chemicals, Other Products), By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities), By Type Of Formulation (Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Drugs Global Market Report 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine And Therapeutic Nutrients, Minerals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter (OTC) Drugs, Prescription-Based Drugs) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the car-t therapy market?

The chimeric antigen receptor -t therapy market consists of sales of car-t therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (car) T-cell therapies to treat blood cancers. request a sample here

How will the car-t therapy market drivers and restraints affect car-t therapy market dynamics? What forces will shape the car-t therapy industry going forward?

The car-t therapy market growth is aided by increase in blood cancer incidence rate. However, some car-t therapy market restraints include the high costs of therapy. request a sample here

What is the forecast market size of the car-t therapy market?

The car-t therapy market forecast is expected to reach $3,150.0 million in 2025 at a compound annual growth rate of 24.9%. request a sample here

How is the car-t therapy market segmented?

The global car-t therapy market is segmented-
a) By Target Antigen
b) By Application request a sample here

Which region has largest share, and what is the market size and growth by geography according to the car-t therapy global market report?

For more detail on this, request a sample here.

Who are the key players of the global car-t therapy market?

Top competitors in the global car-t therapy market are Gilead Sciences; Novartis AG; Gracell Biotechnology Ltd. request a sample here.

What are the key trends in the global car-t therapy market?

Major trends global car-t therapy market include remodeled car-t cell therapy for fewer side effects. request a sample here.

What are the major opportunities in the car-t therapy market and the approaches companies can take to take advantage of them?

For this and further detailed insights on the market, request a sample here. request a sample here.

How does the car-t therapy market relate to the overall economy and other similar markets?

request a sample here.

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

CAR-T Therapy Market Definition

CAR-T Therapy Market Size

CAR-T Therapy Market Drivers

CAR-T Therapy Market Restraints

CAR-T Therapy Market Trends

Opportunities And Recommendations In The CAR-T Therapy Market

CAR-T Therapy Market Segmentation

CAR-T Therapy Competitive Landscape

Major Competitors In The CAR-T Therapy Market Are:

Other Competitors In The CAR-T Therapy Market Include:

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions